TEL AVIV, Israel, Dec. 23, 2024 (Korea Bizwire) - Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva's President and CEO, will present at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2025. The presentation will begin at 8:15 A.M. Pacific Time (11:15 A.M. Eastern Time). To access [...]The post Teva to Present at the 43rd Annual J.P. Morgan Healthcare Conference appeared first on Be Korea-savvy.
Teva is an Israel-based pharmaceutical company that develops and commercializes generic drugs for the treatment of cancer and respiratory diseases around the world.